Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus
- 6 August 2021
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 41 (12) , 2892-2902
Abstract
Background and Aims: Bile acid (BA) dysregulation is related to not only metabolic diseases but also nonalcoholic fatty liver disease (NAFLD). We investigated whether circulating BA levels are altered according to the histological severity of NAFLD independent of metabolic derangements.Methods: Global metabolic profiling and targeted BA analysis using sera collected from biopsy‐proven no‐NAFLD (n = 67), nonalcoholic fatty liver (NAFL) (n = 99), and nonalcoholic steatohepatitis (NASH, n = 75) subjects were performed sequentially. Circulating metabolome analysis integrated with the hepatic transcriptome was performed to elucidate the mechanistic basis of altered circulating BA profiles after stratification by obesity (body mass index ≤ 25 kg/m2). Circulating BA alterations were also validated in an independent validation cohort (29 no‐NAFLD, 70 NAFL and 37 NASH).Results: Global profiling analysis showed that BA was the metabolite significantly altered in NASH compared to NAFL. Targeted BA analysis demonstrated that glyco‐/tauro‐conjugated primary BAs were commonly increased in nonobese and obese NASH, while unconjugated primary BAs increased only in nonobese NASH. These characteristic primary BA level changes were maintained even after stratification according to diabetes status and were replicated in the independent validation cohort. Compared to nonobese NAFL patients, nonobese NASH patients exhibited upregulated hepatic expression of CYP8B1.Conclusions: BA metabolism is dysregulated as the histological severity of NAFLD worsens, independent of obesity and diabetes status; dysregulation is more prominent in nonobese NAFLD patients. Metabolome‐driven omics approach provides new insight into our understanding of altered BA metabolism associated with individual phenotypes of NAFLD.Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2019M3A9D5A01102796, NRF‐2020R1A2C2007835, NRF‐2021M3A9E4021818, NRF‐2021R1A2C2005820)
- Korea Basic Science Institute (C060200)
This publication has 46 references indexed in Scilit:
- Predictive value of ALT levels for NASH and advanced fibrosisNature Reviews Gastroenterology & Hepatology, 2013
- Bile Acid Metabolism and Signaling2013
- Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver diseaseToxicology and Applied Pharmacology, 2013
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of GastroenterologyGastroenterology, 2012
- Risk prediction models: II. External validation, model updating, and impact assessmentHeart, 2012
- Nutritional Regulation of Bile Acid Metabolism Is Associated with Improved Pathological Characteristics of the Metabolic SyndromeJournal of Biological Chemistry, 2011
- Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §ΔHepatology, 2010
- Targeting bile-acid signalling for metabolic diseasesNature Reviews Drug Discovery, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985